Navis Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Navis Wealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$801K	Buy	4,210 +1	+0%	+$172	0.3%	69
2026 Q1	$711K	Buy	4,209 +3	+0.1%	+$513	0.36%	75
2025 Q4	$710K	Buy	4,206 +5	+0.1%	+$812	0.3%	79
2025 Q3	$607K	Buy	4,201 +2	+0%	+$273	0.45%	47
2025 Q2	$531K	Hold	4,199	–	–	0.45%	50
2025 Q1	$537K	Buy	4,199 +4	+0.1%	+$542	0.53%	43
2024 Q4	$555K	Buy	4,195 +2	+0%	+$281	0.61%	40
2024 Q3	$611K	Buy	4,193 +6	+0.1%	+$868	0.66%	38
2024 Q2	$575K	Sell	4,187 -181	-4%	-$24.2K	0.66%	37
2024 Q1	$599K	Buy	4,368 +4	+0.1%	+$546	0.72%	33
2023 Q4	$593K	Buy	4,364 +10	+0.2%	+$1.22K	0.77%	32
2023 Q3	$532K	Hold	4,354	–	–	0.77%	31
2023 Q2	$553K	Hold	4,354	–	–	0.51%	31
2023 Q1	$562K	Buy	4,354 +2	+0%	+$262	0.62%	29
2022 Q4	$571K	Buy	+4,352	New	+$562K	0.81%	27

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Navis Wealth Advisors's IBB Position: Q2 2026 in Review

Navis Wealth Advisors increased its iShares Biotechnology ETF (IBB) stake by 0.02% in Q2 2026, buying an estimated $172 and bringing the position to 4,210 shares worth $801K. The position accounts for 0.3% of the portfolio, ranked #69.

Navis Wealth Advisors first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Navis Wealth Advisors held 4,210 shares of iShares Biotechnology ETF worth $801K as of Q2 2026.
Navis Wealth Advisors bought 1 iShares Biotechnology ETF share in Q2 2026, an estimated $172.
iShares Biotechnology ETF made up 0.3% of Navis Wealth Advisors's portfolio in Q2 2026, its #69 holding.
Navis Wealth Advisors first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Navis Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.